Literature DB >> 18347983

Evaluation for tetanus antibodies in Korean-Americans living in the New York area: a pilot study.

Kumar Alagappan1, Richard Park, Sassan Naderi, Robert Silverman.   

Abstract

Public health initiatives to immunize children and adults have effectively reduced the number of tetanus cases in the USA. However, in the third National Health and Nutrition Examination Survey (NHANES III), immigrants from Mexico had a 67% non-protective anti-tetanus antibody (ATA) level. Less work has been conducted among other immigrant populations to determine the extent of this observation. Objective To measure ATA levels among the Korean-American immigrant population. Methods A convenience sample of 50 Korean Americans born outside the USA was recruited to determine the levels of ATA. A non-protective level of ATA was defined as below 0.15 IU/ml. Results The mean age was 59.5 years and 82% were female. There were 43/50 (86% (95% confidence limits 76, 96)) patients with a non-protective ATA level. Those between the ages of 50-59 years (94% were seronegative) and 60 years-highest age (92% were seronegative) were among the least likely to be protected. Neither gender nor a self-reported history of past tetanus immunization or military service predicted protection to tetanus. Discussion In this pilot study we found that 86% of Korean immigrants did not have protective ATA levels, with patients in the 50-59 year age range as unlikely to be protected as the older subjects. Patient reported history was unreliable in determining whether an individual had protective levels. Conclusion The vast majority of sampled Korean American immigrants lack protective ATA levels and are in need of immunization. Additional study is needed to determine the risk of other immigrant groups to tetanus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347983     DOI: 10.1007/s10903-008-9123-9

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  12 in total

1.  Food and Drug Administration approval of an acellular pertussis vaccine for the initial four doses of the diphtheria, tetanus, and pertussis vaccination series.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1996-08-09       Impact factor: 17.586

2.  Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures.

Authors: 
Journal:  Vital Health Stat 1       Date:  1994-07

3.  Serologic immunity to diphtheria and tetanus in the United States.

Authors:  Geraldine M McQuillan; Deanna Kruszon-Moran; Adamadia Deforest; Susan Y Chu; Melinda Wharton
Journal:  Ann Intern Med       Date:  2002-05-07       Impact factor: 25.391

4.  Seroprevalence of tetanus antibodies among adults older than 65 years.

Authors:  K Alagappan; W Rennie; T Kwiatkowski; J Falck; F Silverstone; R Silverman
Journal:  Ann Emerg Med       Date:  1996-07       Impact factor: 5.721

5.  Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.

Authors:  Katrina Kretsinger; Karen R Broder; Margaret M Cortese; M Patricia Joyce; Ismael Ortega-Sanchez; Grace M Lee; Tejpratap Tiwari; Amanda C Cohn; Barbara A Slade; John K Iskander; Christina M Mijalski; Kristin H Brown; Trudy V Murphy
Journal:  MMWR Recomm Rep       Date:  2006-12-15

6.  Update on the supply of tetanus and diphtheria toxoids and of diphtheria and tetanus toxoids and acellular pertussis vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-03-16       Impact factor: 17.586

7.  Should adult tetanus immunization be given as a single vaccination at age 65? A cost-effectiveness analysis.

Authors:  D J Balestra; B Littenberg
Journal:  J Gen Intern Med       Date:  1993-08       Impact factor: 5.128

8.  A population-based serologic survey of immunity to tetanus in the United States.

Authors:  P J Gergen; G M McQuillan; M Kiely; T M Ezzati-Rice; R W Sutter; G Virella
Journal:  N Engl J Med       Date:  1995-03-23       Impact factor: 91.245

9.  Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds.

Authors:  David A Talan; Fredrick M Abrahamian; Gregory J Moran; William R Mower; Kumar Alagappan; Brian R Tiffany; Charles V Pollack; Mark T Steele; Lala M Dunbar; Mary D Bajani; Robbin S Weyant; Steven M Ostroff
Journal:  Ann Emerg Med       Date:  2004-03       Impact factor: 5.721

10.  Recently occurring adult tetanus in Korea: emphasis on immunization and awareness of tetanus.

Authors:  Dong Hyeon Shin; Ho Sung Yu; Jung Ho Park; Jong Hee Shin; Sei Jong Kim
Journal:  J Korean Med Sci       Date:  2003-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.